share_log

ACADIA Pharmaceuticals, Ocular Therapeutix, Asana And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

ACADIA Pharmaceuticals, Ocular Therapeutix, Asana And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

週二盤前交易中，阿卡迪亞製藥、Ocular Therapeix、Asana和其他大股走低
Benzinga ·  03/12 05:36

U.S. stock futures were mixed this morning, with the Nasdaq futures gaining by around 50 points on Tuesday.

今天上午美國股票期貨漲跌互現，納斯達克期貨週二上漲約50點。

Shares of ACADIA Pharmaceuticals Inc (NASDAQ:ACAD) fell sharply in today's pre-market trading after the company reported the Phase 3 ADVANCE-2 trial evaluating pimavanserin for the treatment of negative symptoms of schizophrenia did not meet the primary endpoint.

阿卡迪亞製藥公司（納斯達克股票代碼：ACAD）的股價在今天的盤前交易中大幅下跌，此前該公司報告稱，評估皮馬萬色林治療精神分裂症陰性症狀的第三階段 ADVANCE-2 試驗未達到主要終點。

ACADIA Pharmaceuticals shares dipped 17.4% to $19.93 in pre-market trading.

阿卡迪亞製藥公司股價在盤前交易中下跌17.4％，至19.93美元。

Here are some big stocks recording losses in today's pre-market trading session.

以下是一些在今天的盤前交易時段中錄得虧損的大型股票。

  • Power & Digital Infrastructure Acquisition II Corp. (NASDAQ:XPDB) shares tumbled 12.6% to $25.57 in pre-market trading after surging 181% on Monday.
  • Ocular Therapeutix, Inc. (NASDAQ:OCUL) shares fell 5.9% to $9.16 in pre-market trading after the company reported worse-than-expected fourth-quarter financial results.
  • Aeva Technologies, Inc. (NASDAQ:AEVA) shares declined 5.4% to $1.23 in pre-market trading. Aeva said it expects a 1-for-5 reverse stock split of its outstanding shares of common stock will be effective as of March 18, 2024.
  • PLDT Inc. (NYSE:PHI) fell 3.8% to $25.95 in pre-market trading after jumping over 16% on Monday.
  • NextNav Inc. (NASDAQ:NN) declined 3.6% to $5.07 in pre-market trading. NextNav shares jumped 35% on Monday after the company announced it signed an agreement to acquire spectrum licenses covering an additional 4 MHz in the lower 900 MHz band.
  • Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) shares fell 3.2% to $2.72 in pre-market trading. Lexicon shares surged over 29% on Monday after the company said it is preparing to resubmit its Sotagliflozin NDA for Type 1 diabetes following FDA feedback. Additionally, the company announced a securities purchase agreement expected to result in gross proceeds of around $250 million.
  • Asana, Inc. (NYSE:ASAN) shares fell 2.4% to $18.35 in pre-market trading following fourth-quarter results.
  • 電力和數字基礎設施收購二公司（納斯達克股票代碼：XPDB）股價在週一飆升181％後，在盤前交易中下跌12.6％，至25.57美元。
  • Ocular Therapeutix, Inc.（納斯達克股票代碼：OCUL）股價在盤前交易中下跌5.9％，至9.16美元，此前該公司公佈的第四季度財務業績低於預期。
  • Aeva Technologies, Inc.（納斯達克股票代碼：AEVA）股價在盤前交易中下跌5.4％，至1.23美元。Aeva表示，預計其已發行普通股的1比5反向股票拆分將從2024年3月18日起生效。
  • PLDT Inc.（紐約證券交易所代碼：PHI）在週一上漲超過16％後，在盤前交易中下跌3.8％，至25.95美元。
  • NextNav Inc.（納斯達克股票代碼：NN）在盤前交易中下跌3.6％，至5.07美元。週一，NextNav股價上漲了35％，此前該公司宣佈簽署了一項協議，以收購涵蓋900 MHz較低頻段中另外4兆赫頻段的頻譜許可。
  • Lexicon Pharmicals, Inc.（納斯達克股票代碼：LXRX）股價在盤前交易中下跌3.2％，至2.72美元。週一，Lexicon股價飆升了29％以上，此前該公司表示準備根據美國食品藥品管理局的反饋重新提交其針對1型糖尿病的Sotagliflozin保密協議。此外，該公司宣佈了一項證券購買協議，預計總收益約爲2.5億美元。
  • 繼第四季度業績公佈後，Asana公司（紐約證券交易所代碼：ASAN）股價在盤前交易中下跌2.4％，至18.35美元。

Now Read This: Top 5 Risk Off Stocks That May Plunge This Quarter

現在讀這個： 本季度可能暴跌的五大避險股票

Don't forget to check out our premarket coverage here

別忘了在這裏查看我們的上市前報道

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論